Entrada Therapeutics (TRDA)
(Real Time Quote from BATS)
$15.56 USD
0.00 (0.00%)
Updated Jul 10, 2024 12:25 PM ET
1-Strong Buy of 5 1
C Value A Growth B Momentum A VGM
Price, Consensus and EPS Surprise
TRDA 15.56 0.00(0.00%)
Will TRDA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for TRDA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TRDA
Strength Seen in Travere (TVTX): Can Its 8.8% Jump Turn into More Strength?
Best Momentum Stocks to Buy for July 9th
TRDA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Kymera's (KYMR) Partner SNY to Expand Ongoing HS and AD Studies
New Strong Buy Stocks for July 9th
Wall Street Analysts Think Entrada Therapeutics (TRDA) Could Surge 37.08%: Read This Before Placing a Bet
Other News for TRDA
Entrada Therapeutics’ ENTR-601-44 Shows Promising Phase 1 Results for DMD, Earns Buy Rating
Entrada Therapeutics price target lowered by $2 at H.C. Wainwright, here's why
Entrada Therapeutics announces $100M registered direct offering
Entrada Therapeutics Announces $100 Million Registered Direct Offering
Entrada to sell 3.37M shares at $14.85 in registered direct offering